Performance reporting through clear and timely information
Enabling better health care while creating a sustained and growing investment opportunity.
If you invest or are considering investing in TSO3, you will want to keep current with the Company’s performance and understand any fluctuations. TSO3’s online Investor Relations section keeps you up-to-date with the latest in financial reporting, including annual reports, quarterly results, and conference call webcasts. As an investment, TSO3 builds value in the health care market through rapid research prototyping. A leading innovator in low-temperature sterilization technology, TSO3 also partners with developers in creating next-generation medical devices to ensure sterilization for these devices will be viable.
|Investor News||Investor Events|
|February 16, 2017: TSO3 Appoints Dr. Linda Rosenstock and Mr. Jeffrey Pompeo to its Board of Directors|
|February 02, 2017: TSO3 Appoints Mark Pasmore as Vice President of Research and Development|
|January 26, 2017: TSO3 Welcomes The Medical University of South Carolina to its Strategic Partner Facility Program|